United States· US:87765-002_57313605-16a6-736a-e063-6394a90a1924

Scalp Soothing

A medicinal product containing piroctone olamine, registered in United States by Guangdong Outeli Biotechnology Co., Ltd.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedScalp SoothingATC—REGISTER NO.US:87765-002_57313605…PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
PIROCTONE OLAMINE
Manufacturer
Guangdong Outeli Biotechnology Co., Ltd
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    87765-002-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca17da2d-bcd5-4f77-8cc2-3a3e50df82c9
GET /v1/drugs/ca17da2d-bcd5-4f77-8cc2-3a3e50df82c9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": ".5",
  "substance": "PIROCTONE OLAMINE",
  "productndc": "87765-002",
  "dosage_form": "POWDER",
  "dea_schedule": null,
  "strength_unit": "g/100g",
  "application_number": "505G(a)(3)",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about piroctone olamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.